Bio is a decentralized science protocol that helps launch and grow AI-driven biotech research. It enables scientists to raise funds, create value from their work, and distribute that value directly to their communities. Since 2023, Bio has directed over $50m to global researchers, offering an alternative to traditional pharma funding. Backed by investors like Binance Labs, Northpond Ventures, and Animoca Brands, Bio accelerates real-world therapeutics across longevity, brain health, fertility, psychedelic science, and more.
Bio is building the infrastructure for decentralized science - from AI agents that accelerate research to the coordination tools that fund and validate it. We sit at the intersection of web3 and biotechnology, creating systems that let researchers, funders, and the scientific community collaborate without gatekeepers. Our stack spans smart contracts, agentic AI, cloud lab integrations, and the interfaces that tie them together.